BioCrea to Present at BIO-Europe in Vienna
(Thomson Reuters ONE) -
BioCrea /
BioCrea to Present at BIO-Europe in Vienna
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Radebeul, Germany, October 30, 2013 - BioCrea GmbH (BioCrea), the first-in-class
CNS drug discovery specialists validated through pharma partnerships, announced
that Dr. Tom Kronbach, CEO, will be presenting at this year's BIO-Europe in
Vienna. The conference takes place from November 4-6, 2013, at the Messe Wien
Exhibition and Congress Center. Tom Kronbach will be presenting on Wednesday,
November 6, 10:45 am CET, in room Schubert 1.
"I am a frequent visitor of BIO-Europe and welcome the conference as industry
networking event", said Dr. Tom Kronbach, Chief Executive Officer of BioCrea.
"Our programs in Depression, Epilepsy, Autism and Huntington's disease are
progressing towards IND-enabling studies and the event provides an ideal
platform for partnering activities".
About BioCrea
BioCrea, the Radebeul-based first-in-class drug discovery specialist validated
through pharma partnerships, has established a number of programs in
neurological and psychotic disorders. Its proven expertise is based on
proprietary compound libraries, medicinal chemistry, molecular modeling and
advanced screening technologies. BioCrea uses this expertise in an innovative
multi-parameter optimization approach to generate and deliver CNS drug
candidates that offer significant potential for greater efficacy and
tolerability. Moreover, the patient-derived stem cell (iPSC) platform has been
successfully developed to discover high value preclinical drug candidates for
neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS, Lou
Gehrig's disease). BioCrea was awarded Top Innovator status of the "Top 100"
Most Innovative Companies in Germany, 2012 by compamedia GmbH.
About BIO-Europe
BIO-Europe® is Europe's largest partnering conference serving the global
biotechnology industry. The conference annually attracts leading dealmakers from
biotech, pharma and finance along with the most exciting emerging companies.
Produced with the support of BIO, it is regarded as a "must attend" event for
the biotech industry.
Contact
Dr. Tom Kronbach
CEO, BioCrea GmbH
Tel.: +49 351 / 4043 3332
Fax: +49 351 / 4043 3216
tom.kronbach(at)biocrea.com
Press Release PDF:
http://hugin.info/156612/R/1739128/583612.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioCrea via Thomson Reuters ONE
[HUG#1739128]
Unternehmensinformation / Kurzprofil:
Datum: 30.10.2013 - 09:00 Uhr
Sprache: Deutsch
News-ID 310705
Anzahl Zeichen: 3308
contact information:
Town:
Radebeul
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 191 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioCrea to Present at BIO-Europe in Vienna"
steht unter der journalistisch-redaktionellen Verantwortung von
BioCrea (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
